| 000 | 01798 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250512200555.0 | ||
| 264 | 0 | _c19850606 | |
| 008 | 198506s 0 0 eng d | ||
| 022 | _a0163-7258 | ||
| 024 | 7 |
_a10.1016/0163-7258(84)90018-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPounder, R E | |
| 245 | 0 | 0 |
_aHistamine H2-receptor antagonists and gastric acid secretion. _h[electronic resource] |
| 260 |
_bPharmacology & therapeutics _c1984 |
||
| 300 |
_a221-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBurimamide _xpharmacology |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry |
| 650 | 0 | 4 |
_aCimetidine _xpharmacology |
| 650 | 0 | 4 |
_aDuodenal Ulcer _xdrug therapy |
| 650 | 0 | 4 |
_aEsophagitis, Peptic _xdrug therapy |
| 650 | 0 | 4 |
_aGastric Acid _xmetabolism |
| 650 | 0 | 4 |
_aGastrins _xmetabolism |
| 650 | 0 | 4 |
_aGastrointestinal Hemorrhage _xdrug therapy |
| 650 | 0 | 4 |
_aHistamine _xphysiology |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aHistamine H2 Antagonists _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity _xdrug therapy |
| 650 | 0 | 4 |
_aIntrinsic Factor _xmetabolism |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMalabsorption Syndromes _xdrug therapy |
| 650 | 0 | 4 |
_aMetiamide _xpharmacology |
| 650 | 0 | 4 |
_aPancreas _xmetabolism |
| 650 | 0 | 4 |
_aPepsin A _xmetabolism |
| 650 | 0 | 4 |
_aRanitidine _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Histamine H2 _xdrug effects |
| 650 | 0 | 4 |
_aStomach Ulcer _xdrug therapy |
| 650 | 0 | 4 |
_aStress, Psychological _xcomplications |
| 650 | 0 | 4 |
_aZollinger-Ellison Syndrome _xdrug therapy |
| 773 | 0 |
_tPharmacology & therapeutics _gvol. 26 _gno. 2 _gp. 221-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0163-7258(84)90018-4 _zAvailable from publisher's website |
| 999 |
_c6152560 _d6152560 |
||